American Journal of Cardiology
Volume 100, Issue 12 , Pages 1767-1770 , 15 December 2007

Relation of Haptoglobin Phenotype to Early Vascular Changes in Patients With Diabetes Mellitus

  • Marina Shor, MD

      Affiliations

    • Department of Internal Medicine, E. Wolfson Medical Center, Tel Aviv University, Tel Aviv, Israel
    • The Brunner Institute for Cardiovascular Research, E. Wolfson Medical Center, Tel Aviv University, Tel Aviv, Israel
    • ,
  • Mona Boaz, PhD

      Affiliations

    • Epidemiology and Research Unit, E. Wolfson Medical Center, Tel Aviv University, Tel Aviv, Israel
    • ,
  • Dov Gavish, MD

      Affiliations

    • Department of Internal Medicine, E. Wolfson Medical Center, Tel Aviv University, Tel Aviv, Israel
    • The Brunner Institute for Cardiovascular Research, E. Wolfson Medical Center, Tel Aviv University, Tel Aviv, Israel
    • Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
    • ,
  • Julio Wainshtein, MD

      Affiliations

    • Diabetes Unit, E. Wolfson Medical Center, Tel Aviv University, Tel Aviv, Israel
    • ,
  • Zipora Matas, PhD

      Affiliations

    • The Brunner Institute for Cardiovascular Research, E. Wolfson Medical Center, Tel Aviv University, Tel Aviv, Israel
    • ,
  • Marina Shargorodsky, MD

      Affiliations

    • The Brunner Institute for Cardiovascular Research, E. Wolfson Medical Center, Tel Aviv University, Tel Aviv, Israel
    • Diabetes Unit, E. Wolfson Medical Center, Tel Aviv University, Tel Aviv, Israel
    • Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
    • Endocrinology Unit, E. Wolfson Medical Center, Tel Aviv, Israel.
    • Corresponding Author InformationCorresponding author: Tel: 972-3-502-8614; fax: 972-3-503-2693.

Received 22 April 2007 ,Revised 1 July 2007 ,Accepted 1 July 2007.

References 

  1. Cohn JN, Finkelstein S, McVeigh G, Morgan D, LeMay I, Robinson J, et al. Non-invasive pulse wave analysis for the detection of arterial vascular disease. Hypertension. 1995;26:503–508
  2. Salomaa V, Riley W, Kark JD, Nardo C, Folsom AR. Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentration are associated with arterial stiffness indexes. The ARIC Study. Atherosclerosis Risk in Communities Study. Circulation. 1995;91:1432–1443
  3. van Popele NM, Grobbee DE, Bots ML, Asmar R, Topouchian J, Reneman RS, et al. Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke. 2001;32:454–460
  4. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation. 1999;99:2434–2439
  5. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236–1241
  6. Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance (An integrated index of vascular function?). Circulation. 2002;106:2085–2090
  7. Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol. 2005;25:932–943
  8. Giannattasio C, Mancia G. Arterial distensibility in humans (Modulating mechanisms, alterations in diseases and effects of treatment). J Hypertens. 2002;20:1889–1899
  9. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. JAMA. 2001;285:2486–2497
  10. Langllois MR, Delanghe JR. Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem. 1996;42:1589–1600
  11. Smithies O. Zone electrophoresis in starch gels: group variations in the serum proteins of normal human adults. Biochemistry. 1955;61:629–641
  12. Shargorodsky M, Leibovitz E, Lubimov L, Gavish D, Zimlichman R. Prolonged treatment with the AT1 receptor blocker, valsartan, increases small and large artery compliance in uncomplicated essential arterial hypertension. Am J Hypertens. 2002;15:1087–1091
  13. McVeigh GE, Burns DE, Finkelstein SM, McDonald KM, Mock JE, Feske W, et al. Reduced vascular compliance as a marker for essential hypertension. Am J Hypertens. 1991;4:245–257
  14. Zimlichman R, Shargorodsky M, Boaz M, Duprez D, Rahn KH, Rizzoni D, et al. Determination of arterial compliance using blood pressure waveform analysis with the CR-2000 system. Am J Hypertens. 2005;18:65–71
  15. Levy AP, Roguin A, Marsh S, Nakhoul FM, Herer P, Hochberg I, et al. Haptoglobin phenotype and vascular complications in diabetes. N Engl J Med. 2000;343:969–970
  16. Nakhoul F, Marsh S, Hochberg I, Leibu R, Miller BP, Levy AP. Haptoglobin phenotype and diabetic retinopathy. JAMA. 2000;284:1244–1245
  17. Levy AP, Hochberg I, Jablonski K, Resnic HE, Lee ET, Best L, et al. Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: the Strong Heart Study. J Am Coll Cardiol. 2002;40:1984–1990
  18. Suleiman M, Aronson D, Asleh R, Kapeliovich MR, Roguin A, Meisel SR, et al Haptoglobin polymorphism predicts 30-day mortality and heart failure in patients with diabetes and acute myocardial infarction. Diabetes. 2005;54:2802–2806
  19. Guigliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetic Care. 1996;19:257–267
  20. Gutteridge JM. The antioxidant activity of haptoglobin towards hemoglobin-stimulated lipid peroxidation. Biochem Biophys Acta. 1987;917:219–223
  21. Collins P, Burman J, Chung H, Fox K. Hemoglobin inhibits endothelium-dependent relaxation to acetylcholine in human coronary arteries in vivo. Circulation. 1993;87:80–85
  22. Delanghe J, Duprez D, De Buyzere M, Bergez B, Callens B, Leroux-Roels G, et al. Haptoglobin phenotypes and complications in established essential arterial hypertension. J Hypertens. 1993;11:861–867
  23. Braeckman L, De Bacquer D, Delanghe J, Claeys L, De Backer G. Association between haptoglobin polymorphism, lipids, lipoproteins and inflammatory variables. Atherosclerosis. 1999;143:383–388

PII: S0002-9149(07)01674-8

doi: 10.1016/j.amjcard.2007.07.052

American Journal of Cardiology
Volume 100, Issue 12 , Pages 1767-1770 , 15 December 2007

Article Tools

* Image Usage & Resolution